EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 138 filers reported holding EPIZYME INC in Q4 2019. The put-call ratio across all filers is 0.33 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $22,000 | +29.4% | 15,000 | 0.0% | 0.00% | +100.0% |
Q1 2022 | $17,000 | -55.3% | 15,000 | 0.0% | 0.00% | -66.7% |
Q4 2021 | $38,000 | -65.1% | 15,000 | -29.2% | 0.00% | -66.7% |
Q3 2021 | $109,000 | -35.1% | 21,200 | +5.0% | 0.01% | -30.8% |
Q2 2021 | $168,000 | -4.5% | 20,200 | 0.0% | 0.01% | -23.5% |
Q1 2021 | $176,000 | -88.4% | 20,200 | -85.6% | 0.02% | -89.2% |
Q4 2020 | $1,518,000 | +7.4% | 139,800 | +18.1% | 0.16% | -5.4% |
Q3 2020 | $1,413,000 | -10.8% | 118,400 | +20.1% | 0.17% | -19.3% |
Q2 2020 | $1,584,000 | +77.6% | 98,600 | +71.5% | 0.21% | +56.8% |
Q1 2020 | $892,000 | +68.0% | 57,500 | +166.2% | 0.13% | +140.0% |
Q4 2019 | $531,000 | – | 21,600 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |